BioSpace News Archive

Tauriga Sciences, Inc., a New York based diversified Life Sciences Company, introduced the Company’s Super Deluxe Rainbow Pack, which is comprised of 1 Blister Pack.

Yourway, the only truly integrated premium courier and clinical packager in the clinical trials supply chain market, announced an expansion underway at its headquarters in Allentown, Pennsylvania.

AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (”AREV” or the “Company”) is pleased to announce it has expanded its extraction results to Clinical Characterization of Compounds and provides this update of corporate developments consistent with its news announcements and AREV’s transformed corporate website now located at www.arevlifesciences.com

The innovation is a result of Halberd’s Sponsored Research conducted at Arizona State University (ASU).

AD and PD patients both respond with a statistically significant increase in correctly coded fields after 25 days of treatment with ANVS401.

The report highlights the trends prevailing in the global allergy treatment market, along with market drivers and deterrents.

Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune disease, announces a new collaboration and supply agreement with Merck KGaA , Darmstadt, Germany for a Phase I/IIa clinical trial in patients with solid tumours, called INSIGHT-005.

With this new appointment, the market leader in transcranial magnetic stimulation will continue expanding treatment access for patients with Major Depressive Disorder

Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases, today announced that the results from the Phase 3 long-term safety and efficacy study conducted in Japan by its development partner, Kaken Pharmaceutical Co., Ltd.

Telix Pharmaceuticals Limited announces that Chief Executive Officer, Dr. Christian Behrenbruch, will present at the Jefferies Virtual Healthcare Conference 2021.